A. Vandebroek

Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia

Laurent Bastit, A. Vandebroek, Sevilay Altıntaş et al. · Journal of Clinical Oncology · 2008 · 194 citations · Full text

Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer

Abdelbari Baitar, Frank Van Fraeyenhove, A. Vandebroek et al. · Journal of Geriatric Oncology · 2012 · 133 citations · Full text

Geriatric Oncology, Aging, Screening Tools +9

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study

Gontran Verset, Chris Verslype, Hendrik Reynaert et al. · British Journal of Cancer · 2007 · 38 citations · Full text

Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy

Abdelbari Baitar, Frank Van Fraeyenhove, A. Vandebroek et al. · Journal of Geriatric Oncology · 2014 · 29 citations

Geriatric Oncology, Oncology, Radiation Therapy +9